There are multiple and independent biomarkers, including serum AFP, CEUS, PET and MRI imaging and tissue IHC, available for use in preclinical animal studies investigating novel compounds and therapeutic combination paradigms for HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.